These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8255496)

  • 61. Future developments in the treatment of immune-mediated polyneuropathies.
    van der Meché FG; van Doorn PA
    Eur Neurol; 1997; 38(3):230-7. PubMed ID: 9363836
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative study of efficacy of plasma exchange versus intravenous gammaglobulin treatment on acute postinfectious polyradiculoneuropathy: a preliminary report.
    Hosokawa T; Hamaguchi K; Tomioka R; Tsuji T; Nomura K; Ohno R; Okada H; Moriwaki K; Sugawara S; Nakamoto H; Suzuki H; Shimazu K
    Ther Apher; 1998 Nov; 2(4):288-91. PubMed ID: 10227757
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Treatment of Guillain-Barré Syndrome].
    Nomura K
    Brain Nerve; 2015 Nov; 67(11):1397-410. PubMed ID: 26560955
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Guillain-Barré syndrome following chickenpox: a case series.
    Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
    Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Compatibility problems after intravenous immunoglobulin--a case report.
    Sulochana PV; Mathai J; Sathyabhama S; Augustine P
    Indian J Pathol Microbiol; 1998 Oct; 41(4):495-8. PubMed ID: 9866917
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Steroids in the Guillain-Barré syndrome: is there a therapeutic window?
    Van Koningsveld R; Van Doorn PA
    Neurologia; 2005 Mar; 20(2):53-7. PubMed ID: 15726470
    [No Abstract]   [Full Text] [Related]  

  • 67. Rational therapy of Guillain-Barré syndrome.
    Berciano J
    Lancet; 1998 Mar; 351(9104):754-5. PubMed ID: 9504544
    [No Abstract]   [Full Text] [Related]  

  • 68. Rapid recovery of a child with Guillain-Barré syndrome using intravenous immunoglobulins.
    Shah M; Weinberger M
    J La State Med Soc; 1998 Nov; 150(11):533-7. PubMed ID: 9861805
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous immune globulin versus plasma exchange in Guillain-Barré syndrome.
    Raphael JC; Chastang C; Chevret S; Gajdos P
    N Engl J Med; 1992 Sep; 327(11):816; author reply 817. PubMed ID: 1501669
    [No Abstract]   [Full Text] [Related]  

  • 70. [A case of Guillain-Barré syndrome treated with plasma exchange and intravenous high-dose immune globulin].
    Imai N; Miyata K; Terayama Y; Ishihara N
    Rinsho Shinkeigaku; 1997 Jun; 37(6):520-2. PubMed ID: 9366182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Guillain-Barré syndrome: diagnosis, treatment and prognosis.
    van der Meché FG
    Acta Neurol Belg; 1994; 94(2):124-7. PubMed ID: 8036879
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rational therapy of Guillain-Barré syndrome.
    Samman I; Wöhrle JC; Hennerici M
    Lancet; 1998 Mar; 351(9104):753-4. PubMed ID: 9504543
    [No Abstract]   [Full Text] [Related]  

  • 73. [Treatment of Guillain-barre syndrome: immunoglobulins or plasmapheresis?].
    Martínez Yélamos A; Huerta Villanueva M; Olivé Plana M; Montero Homs J; Serra Catafau J; Martínez-Matos JA
    Neurologia; 1998 Apr; 13(4):166-9. PubMed ID: 9608755
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Confirmation of the utility of plasma-exchange in the treatment of severe Guillain-Barré syndrome.
    Garelli S
    Riv Emoter Immunoematol; 1980; 27(3-4):187-94. PubMed ID: 7339847
    [No Abstract]   [Full Text] [Related]  

  • 75. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group.
    Visser LH; Van der Meché FG; Van Doorn PA; Meulstee J; Jacobs BC; Oomes PG; Kleyweg RP; Meulstee J
    Brain; 1995 Aug; 118 ( Pt 4)():841-7. PubMed ID: 7655882
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-dose intravenous immune globulin in the management of severe Guillain-Barre syndrome.
    Baskin E; Turkay S; Icagasioglu D; Tanzer F; Cevit O
    Turk J Pediatr; 1996; 38(1):119-23. PubMed ID: 8819632
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of Guillain-Barré syndrome with intravenous methylprednisolone.
    Hughes R; Swan A
    Ann Neurol; 1995 May; 37(5):683-4. PubMed ID: 7755366
    [No Abstract]   [Full Text] [Related]  

  • 78. Management of inflammatory neuropathies.
    Hadden RD; Hughes RA
    J Neurol Neurosurg Psychiatry; 2003 Jun; 74 Suppl 2(Suppl 2):ii9-ii14. PubMed ID: 12754323
    [No Abstract]   [Full Text] [Related]  

  • 79. Guillain-Barré syndrome: multifactorial mechanisms versus defined subgroups.
    van der Meché FG; Visser LH; Jacobs BC; Endtz HP; Meulstee J; van Doorn PA
    J Infect Dis; 1997 Dec; 176 Suppl 2():S99-102. PubMed ID: 9396690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Guillain-Barré disease: a current treatment method using immunoglobulins].
    Kleyweg RP; van der Meché FG
    Ned Tijdschr Geneeskd; 1992 Oct; 136(40):1956-60. PubMed ID: 1328903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.